• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

NAITO Kensuke  内藤 健助

ORCIDConnect your ORCID iD *help
Researcher Number 40334990
External Links
Affiliation (based on the past Project Information) *help 2004: Hamamatsu Univ.Sch.Med., Faculty of Med, Assistant Professor, 医学部, 助手
2002 – 2004: 浜松医科大学, 医学部, 助手
Review Section/Research Field
Except Principal Investigator
Hematology
Keywords
Except Principal Investigator
CD33 / P glycoprotein / drug resistance / target oriented therapy / monoclonal antibody / minimal residual disease / acute promyelocytic leukemia / acute myeloid leukemia / 耐性克服剤 / CD34 … More / 急性白血病 / P糖蛋白質 / P糖タンパク / 薬剤耐性 / 分子標的療法 / モノクーローナル抗体 / 微小残存病変 / 急性前骨髄球性白血病 / 急性骨髄性白血病 Less
  • Research Projects

    (1 results)
  • Research Products

    (8 results)
  • Co-Researchers

    (3 People)
  •  Enhancement of purging for minimal residual disease by anti-CD33 monoclonal antibody and multidrug resistant modifiers

    • Principal Investigator
      TAJKESHITA Akihiro
    • Project Period (FY)
      2002 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Hematology
    • Research Institution
      Hamamatsu University School of Medicine

All 2004 2003 2002 Other

All Journal Article

  • [Journal Article] del(6p23) and der(11p15) including NUP98 translocation in a case of secondary myeloproliferative disorder which eventually underwent clonal evolution and transformed to acute myeloid leukemia.2004

    • Author(s)
      Takeshita A, Naito K, et al.
    • Journal Title

      Cancer Genet Cytogenet 152

      Pages: 56-60

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570972
  • [Journal Article] Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukaemia (APL) and As_2O_3-resistant APL cell lines than As_2O_3 by activating the mitochondrial pathway.2004

    • Author(s)
      Sahara N, Takeshita A, Shigeno K, Fujisawa S, Takeshita K, Naito K, Ihara M, Ono T, Tamashima S, Nara K, Ohnishi K, Ohno R.
    • Journal Title

      Leukemia and Lymphoma. 45

      Pages: 987-995

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570972
  • [Journal Article] del(6p23) and der(11p15) including NUP98 translocation in a case of secondary myeloproliferative disorder which eventually underwent clonal evolution and transformed to acute myeloid leukemia.2004

    • Author(s)
      Takeshita A, Naito K, Shinjo K, Nakamura S, Sahara N, Matui H, Ohnishi K, Beppu H, Ohtsubo K, Hisatomi H, Horii T, Maekawa M, Inaba T, Ryuzo Ohno.
    • Journal Title

      Cancer Genet Cytogenet 152

      Pages: 56-60

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570972
  • [Journal Article] Impairment of heart rate variability control during arsenic trioxide treatment for acute promyelocytic leukemia.2004

    • Author(s)
      Takeshita A, Uehara A, Shinjo K, Naito K, Sahara N, Yamazaki K, Katoh H, Kamikawa T, Ohnishi K, Maekawa M, Hayashi H, Ohno.
    • Journal Title

      Leukemia 18

      Pages: 647-648

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570972
  • [Journal Article] Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias.2004

    • Author(s)
      Shigeno K, Yoshida H, Pan L, Luo JM, Fujisawa S, Naito K, Nakamura S, Shinjo K, Takeshita A, Ohno R, Ohnishi K.
    • Journal Title

      Cancer Lett. 213

      Pages: 11-20

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570972
  • [Journal Article] P-glycoprotein (P-gp) can be induced by arsenic trioxide (As_2O_3) therapy, but is not the main mechanism of As_2O_3-resistance in acute promyelocytic leukemia cells : analysis of P-gp and intracellular concentration of As_2O_3.2003

    • Author(s)
      Takeshita A, Shinjo K, Naito K, Fujisawa S, Shigeno K, Horii T, Maekawa M, Izumi M, Kitamura K, Ohnishi K, Naoe T, Ohno R.
    • Journal Title

      Leukemia 17

      Pages: 648-650

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570972
  • [Journal Article] Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug-resistance modifiers.2002

    • Author(s)
      Matsui H, Takeshita A, Naito K, Shinjo K, Shigeno K, Maekawa M, Yamakawa Y, Tanimoto M, Kobayashi M, Ohnishi K, Ohno R.
    • Journal Title

      Leukemia 16

      Pages: 813-819

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570972
  • [Journal Article] Efficacy of gemtuzumab ozogamicin on ATRA-and arsenic-resistant acute promyelocytic leukemia (APL) cells.

    • Author(s)
      Takeshita A, Shinjo K, Naito K, Matsui H, Sahara N, Shigeno K, Horii T, Shirai N, Maekawa M, Ohnishi K, Naoe T, Ohno R.
    • Journal Title

      Leukemia (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570972
  • 1.  TAJKESHITA Akihiro (00242769)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 8 results
  • 2.  MAEKAWA Masato (20190291)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 5 results
  • 3.  OHNISHI Kazunori (80252170)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 7 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi